{
    "nct_id": "NCT04569799",
    "official_title": "Accuracy of Contrast-Enhanced Ultrasound for Hepatocellular Carcinoma (HCC) Post Transcatheter Arterial Chemoembolization (TACE)",
    "inclusion_criteria": "* Adult (≥18 years of age) patients with diagnosed HCC (via imaging, biopsy, or combination of imaging and biochemical markers), who are treated with their first round of TACE.\n* Sex: male or female\n* BMI ≤ 40\nHealthy volunteers allowed\nMust have minimum age of 18 Years",
    "exclusion_criteria": "* Children (<18), pregnant patients\n* Patients who do not speak English\n* Patients with a history of hypersensitivity reactions to sulfur hexafluoride lipid microsphere components or to any of the inactive ingredients in Lumason.\n* Patients with unstable cardiopulmonary conditions (acute myocardial infarction, acute coronary artery syndromes, worsening or unstable congestive heart failure, or serious ventricular arrhythmias)\n* Patients who have a prior non-contrast ultrasound, within last 3 months (at time of consent), where the tumor could not be seen - most commonly due to severe steatosis or obesity.\n* Pregnant or nursing woman\n* Patients who do not plan to get their follow-up CT/MRI at Hershey Medical Center.",
    "miscellaneous_criteria": ""
}